IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v32y2014i9p841-851.html
   My bibliography  Save this article

The Burden of Disease in Rheumatoid Arthritis

Author

Listed:
  • Till Uhlig
  • Rikke Moe
  • Tore Kvien

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease which, if left untreated, leads to functional disability, pain, reduced health-related quality of life and premature mortality. Between 0.5 % and 1 % of the population are affected worldwide, and between 25 and 50 new cases evolve in a population of 100,000. Practically all patients with RA require initiation with disease-modifying antirheumatic treatment to retard or stop progression, control disease manifestations and reduce the disease burden. If disease course is monitored with adjustment of medication, lifestyle factors, and exercise, as well as physical activity levels, co-morbidities may be prevented in the course of RA. During the last decade, major progress has been made in treating RA through early identification and treatment of the disease. Many patients still experience premature work disability and co-morbidities. For societies, the economic burden of RA is high in terms of direct and indirect costs, including modern drug treatment. Copyright Springer International Publishing Switzerland 2014

Suggested Citation

  • Till Uhlig & Rikke Moe & Tore Kvien, 2014. "The Burden of Disease in Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 32(9), pages 841-851, September.
    • Handle: RePEc:spr:pharme:v:32:y:2014:i:9:p:841-851
    DOI: 10.1007/s40273-014-0174-6
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s40273-014-0174-6
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s40273-014-0174-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Massimo Radin & Marta Arbrile & Irene Cecchi & Pierluigi Di Nunzio & Nicola Buccarano & Federico Di Gregorio & Valeria Milone & Sara Osella & Paola Crosasso & Marika Denise Favuzzi & Alice Barinotti &, 2022. "Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App," IJERPH, MDPI, vol. 19(9), pages 1-11, April.
    2. Xavier Janssens & Saskia Decuman & Filip De Keyser & Belgian Rheumatoid Arthritis Disability Assessment study group, 2016. "Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis," PLOS ONE, Public Library of Science, vol. 11(1), pages 1-11, January.
    3. Monika Laugesen & Mette Rasmussen & Robin Christensen & Hanne Tønnesen & Henning Bliddal, 2022. "Smoking Cessation Rates among Patients with Rheumatoid Arthritis and Osteoarthritis Following the ‘Gold Standard Programme’ (GSP): A Prospective Analysis from the Danish Smoking Cessation Database," IJERPH, MDPI, vol. 19(10), pages 1-14, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:32:y:2014:i:9:p:841-851. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.